Bionano Genomics, Inc. Deposit Liability, Current
Bionano Genomics, Inc. (BNGO) had Deposit Liability, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Other Liabilities
us-gaap:DepositLiabilityCurrent · last filed 2026-03-23
- 2025-12-31: Deposit Liability, Current $0.00.
- 2025-09-30: Deposit Liability, Current $0.00.
- 2025-06-30: Deposit Liability, Current $0.00.
- 2025-03-31: Deposit Liability, Current $0.00.
| Period end | Deposit Liability, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-23 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $17.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $17.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $17.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $17.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $17.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $17.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $17.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $17.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $17.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $6.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $73.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $979.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $826.00K 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |